{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-045855","form_type":"8-K","ticker":"IMCR","cik":"0001671927","company_name":"Immunocore Holdings plc","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.179225+00:00","generated_at":"2026-05-30T02:52:00.786605+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Immunocore prepays $52M Pharmakon loan, terminating agreement 4 years early","bullets":["Immunocore prepaid $52M ($50M principal, $0.5M interest, $1.5M prepayment premium) on Nov 8, 2024.","Full repayment terminates all obligations under Pharmakon Loan Agreement originally due Nov 8, 2028.","Loan was from BioPharma Credit entities; collateral agent BioPharma Credit PLC.","Subsidiary Immunocore Limited was borrower; parent Immunocore Holdings as credit party."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-045855","json":"https://secwatch.observer/filing/0001140361-24-045855.json","markdown":"https://secwatch.observer/filing/0001140361-24-045855.md","text":"https://secwatch.observer/filing/0001140361-24-045855.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124045855/0001140361-24-045855-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124045855/ef20038285_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:52:00.786605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}